PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Agache, I.* ; Annesi-Maesano, I.* ; Bonertz, A.* ; Branca, F.* ; Cant, A.* ; Fras, Z.* ; Ingenrieth, F.* ; Namazova-Baranova, L.* ; Odemyr, M.* ; Spanevello, A.* ; Vieths, S.* ; Yorgancioglu, A.* ; Alvaro-Lozano, M.* ; Hernandez, D.B.* ; Chivato, T.* ; Giacco, S.D.* ; Diamant, Z.* ; Eguiluz-Gracia, I.* ; Gert van Wijk, R.* ; Gevaert, P.* ; Graessel, A.* ; Hellings, P.W.* ; Hoffmann-Sommergruber, K.* ; Jutel, M.* ; Lau, S.* ; Lauerma, A.* ; Olaguibel, J.M.* ; O'Mahony, L.* ; Ozdemir, C.* ; Palomares, O.* ; Pfaar, O.* ; Sastre, J.* ; Scadding, G.* ; Schmidt-Weber, C.B. ; Schmid-Grendelmeier, P.* ; Shamji, M.* ; Skypala, I.* ; Spinola, M.* ; Spranger, O.* ; Torres, M.* ; Vereda, A.* ; Bonini, S.*

Prioritizing research challenges and funding for allergy and asthma and the need for translational research-The European Strategic Forum on Allergic Diseases.

Allergy 74, 2064-2076 (2019)
Verlagsversion Postprint DOI PMC
Open Access Green
The European Academy of Allergy and Clinical Immunology (EAACI) organized the first European Strategic Forum on Allergic Diseases and Asthma. The main aim was to bring together all relevant stakeholders and decision-makers in the field of allergy, asthma and clinical Immunology around an open debate on contemporary challenges and potential solutions for the next decade. The Strategic Forum was an upscaling of the EAACI White Paper aiming to integrate the Academy's output with the perspective offered by EAACI's partners. This collaboration is fundamental for adapting and integrating allergy and asthma care into the context of real-world problems. The Strategic Forum on Allergic Diseases brought together all partners who have the drive and the influence to make positive change: national and international societies, patients' organizations, regulatory bodies and industry representatives. An open debate with a special focus on drug development and biomedical engineering, big data and information technology and allergic diseases and asthma in the context of environmental health concluded that connecting science with the transformation of care and a joint agreement between all partners on priorities and needs are essential to ensure a better management of allergic diseases and asthma in the advent of precision medicine together with global access to innovative and affordable diagnostics and therapeutics.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
6.771
1.931
24
21
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Allergic Diseases ; Asthma ; Big Data ; Environmental Health ; Exposome ; Implementation Science ; Quality Criteria ; Translational Research; Precision Medicine; Implementation Science; Drug Development; Food Allergy; Opportunities; Association; Biomarkers; Guidelines; Exposome; Birth
Sprache englisch
Veröffentlichungsjahr 2019
HGF-Berichtsjahr 2019
ISSN (print) / ISBN 0105-4538
e-ISSN 1398-9995
Zeitschrift Allergy
Quellenangaben Band: 74, Heft: 11, Seiten: 2064-2076 Artikelnummer: , Supplement: ,
Verlag Wiley
Verlagsort 111 River St, Hoboken 07030-5774, Nj Usa
Begutachtungsstatus Peer reviewed
Institut(e) Institute for Allergy Research (IAF)
POF Topic(s) 30202 - Environmental Health
Forschungsfeld(er) Allergy
PSP-Element(e) G-505400-001
DOI 10.1111/all.13856
WOS ID WOS:000493013000005
Scopus ID 85067038591
PubMed ID 31070805
Erfassungsdatum 2019-05-15
[➜Korrektur melden]